AJJ Medtech says Chong Eng Wee has not formally notified board of plan to retire or skip re-election at next AGM
Reuters2026/08/13 12:32- AJJ Medtech responded to SGX queries on director Chong Eng Wee’s capacity to serve amid multiple listed-company directorships.
- The board cited Chong’s full attendance, preparation, responsiveness, governance support during disputes, and deep familiarity with the business since 2020.
- It also pointed to his legal background as supporting effective oversight of corporate governance, risk management, regulatory compliance.
- No formal notice received that Chong will retire or skip re-election at the next AGM.
- The board noted he previously told the executive chairman he intends to step down as an independent non-executive director.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Goldman Sachs remains bullish on the South Korean stock market: Driven by the AI memory boom, with a potential upside of up to 80%.
Goldman Sachs strategist Timothy Moe maintains his bullish target on the South Korean stock market, believing that investors are underestimating how long the benefits of artificial intelligence (AI) will last for the country's memory chip manufacturers.
Oranjebtc cancels 25 million treasury shares without capital reduction
The Last Time Treasury Yields Hit 6%, Bitcoin Didn't Exist — What Happens If They Get There Again?
Crypto prices
More
